Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

microRNAs (miRNAs) are small noncoding RNAs involved in a large range of cellular activities and can be used as biomarkers and indicators for diagnosis. We investigated the alterations in miRNA profiles in immune reconstituted vs. nonimmune reconstituted HIV-1-infected individuals to assess the association between miRNAs and the occurrence of immunological nonresponses, with the aim of searching for miRNA-based biomarkers for these HIV-1-infected individuals. Thirteen immunological responders (IRs) and 12 immunological nonresponders (INRs) were recruited, and RNA was collected from the plasma samples of the 25 HIV-1-infected individuals at both baseline and after 24 months of maintaining virological suppression (VS). Next-generation sequencing was used to detect miRNAs and evaluate the expression differences in miRNAs between IR and INR patients and between baseline and after 24 months of maintaining VS. Samples from 13 IRs and 11 INRs were successfully sequenced. The horizontal comparison of differentially expressed miRNAs between the groups and the longitudinal comparison of differentially expressed miRNAs between baseline and after 24 months of maintaining VS showed that a large proportion of miRNAs in INRs are downregulated compared to the levels in IRs. We also found that the miRNA let-7d-5p was downregulated in 9 INRs but only in 2 IRs by more than 2-fold. The difference was significant. In summary, these results demonstrate for the first time that a large proportion of miRNAs are downregulated in INRs compared with IRs, and the miRNA let-7d-5p is a potential biomarker for INRs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735831PMC
http://dx.doi.org/10.1155/2020/5782927DOI Listing

Publication Analysis

Top Keywords

hiv-1-infected individuals
12
baseline months
12
months maintaining
12
mirnas
8
comparison differentially
8
differentially expressed
8
expressed mirnas
8
large proportion
8
proportion mirnas
8
irs mirna
8

Similar Publications

Frequency of the CCR5Δ32 Variant in Haematopoietic Progenitor Cell Donors From Argentina: Implications for Transplantation in HIV-1 Infected Patients.

J Med Virol

September 2025

Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) - UCT, INCUCAI, Ciudad Autónoma de Buenos Aires, Argentina.

The genetic variant CCR5Δ32 is mostly represented in European populations and has been studied for its protective effect against human immunodeficiency virus (HIV) infection. The Berlin patient and others have received a haematopoietic stem cell (HSC) transplant from CCR5Δ32/Δ32-HLA compatible donors and are considered cured for HIV. Several studies emphasize the need to seek donors with this condition in the HSC registries.

View Article and Find Full Text PDF
Article Synopsis
  • Tissue-resident memory T cells (Trms) play a crucial role in mucosal immunity, particularly in the gut, and their persistence is linked to HIV-1 survival.
  • Researchers utilized advanced sequencing techniques to analyze gut CD4 and CD8 T cells from HIV-1 patients, finding that the transcription factor BACH2 helps shape Trms into long-lasting memory cells, limiting their effector functions.
  • The study revealed that HIV-1 primarily infected the BACH2-shaped Trms, contributing to the virus's ability to evade the immune response in the gut.
View Article and Find Full Text PDF

To explore the distribution of HIV-1 genetic subtypes and drug resistance profiles among HIV-1 infected patients with antiretroviral treatment (ART) failure in Henan Province and to provide evidence for optimizing ART regimens. HIV-1 infected patients who had received ART for at least 6 months with viral loads (VL) ≥200 copies/ml in 18 cities of Henan from January to December 2023. The plasma samples were collected, and partial gene sequences and full-length integrase () gene sequences of HIV-1 were amplified using nested RT-PCR.

View Article and Find Full Text PDF

Background and objectives Efavirenz (EFV) exhibits substantial inter-patient pharmacokinetics (PK) variability. Polymorphisms in genes involved in EFV metabolism have been associated with EFV exposure, but they have not been fully implemented to inform dosing in treatment guidelines. This work aimed to develop a population pharmacokinetic-pharmacogenetic (PopPK-PGx) model of EFV in human immunodeficiency virus type 1 (HIV-1)-positive patients, and to simultaneously explore the influence of CYP2B6(516G>T and c.

View Article and Find Full Text PDF

The clearance of human immunodeficiency virus-1 (HIV-1) remains a significant public health challenge due to impaired cellular immune responses and HIV-1 maintenance during acute infection. However, the genetic and epigenetic changes influencing the immune response on host infected cells remain unclear. Here, this study analyzes HIV-1-infected CD4+ T cells from peripheral blood mononuclear cells from people living with HIV-1 during early infection (<6 months) using single-cell RNA and ATAC sequencing.

View Article and Find Full Text PDF